Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

McMaster University

$125,000.00

Prototype validation for an automated lutetium-177 processing system

FY 2021-22

Summary
Lutetium-177 (Lu-177) is a sought-after medical isotope for treating a wide range of cancers. This isotope is currently produced at a handful of high flux nuclear reactors around the world by exposing the stable isotope Yb-176 to neutrons, and then chemically separating the Lu-177. Our group has developed a new process for separating Lu-177 that is more efficient than the industry standard. It can be used to process material from both high flux and medium flux reactors, which will expand and diversify the supply chain for this increasingly important medical isotope. It also generates less radioactive waste than the standard method. However, the new process is not compatible with clinical production environments, where chemical separations have to be automated to maintain quality standards and protect technicians from radiation exposure.The work proposed here will enable us to test a prototype that can be used for automated, hands-free, processing of Lu-177 using our new separation method. The prototype will be tested with low, intermediate, and high levels of Lu-177, which will be subjected to full quality testing each time to verify that it meets standards for clinical use. With these experiments completed, we can begin to deploy this technology to facilities around the world to increase the global supply of this isotope.
Program
Idea to Innovation
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
566692-2021
Name nom
Armstrong, Andrea
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
7000
Research subject group en
Other studies in natural sciences and engineering
Research subject group fr
Autres études en sciences naturelles et en génie
Research subject en
Other studies in natural sciences and engineering
Research subject fr
Autres études en sciences naturelles et en génie
Installment
inst:1
Partie
1
Nb partie
1
Application title
Prototype validation for an automated lutetium-177 processing system
Keyword
NSERC
Application summary
Lutetium-177 (Lu-177) is a sought-after medical isotope for treating a wide range of cancers. This isotope is currently produced at a handful of high flux nuclear reactors around the world by exposing the stable isotope Yb-176 to neutrons, and then chemically separating the Lu-177. Our group has developed a new process for separating Lu-177 that is more efficient than the industry standard. It can be used to process material from both high flux and medium flux reactors, which will expand and diversify the supply chain for this increasingly important medical isotope. It also generates less radioactive waste than the standard method. However, the new process is not compatible with clinical production environments, where chemical separations have to be automated to maintain quality standards and protect technicians from radiation exposure.The work proposed here will enable us to test a prototype that can be used for automated, hands-free, processing of Lu-177 using our new separation method. The prototype will be tested with low, intermediate, and high levels of Lu-177, which will be subjected to full quality testing each time to verify that it meets standards for clinical use. With these experiments completed, we can begin to deploy this technology to facilities around the world to increase the global supply of this isotope.
McMaster University - $125,000 Grant (2021-22) | Canada Spends